AML with t (7; 12)(q36; p13) is associated with infancy and trisomy 19. Data from NOPHO-AML and review of the literature
ADL Espersen, U Noren-Nyström… - Genes, Chromosomes …, 2018 - pure.au.dk
Abstract The t (7; 12)(q36; p13)(MNX1/ETV6) is not included in the WHO classification but
has been described in up to 30% of acute myeloid leukemia (AML) in children< 2 years and …
has been described in up to 30% of acute myeloid leukemia (AML) in children< 2 years and …
Acute myeloid leukemia (AML) with t (7; 12)(q36; p13) is associated with infancy and trisomy 19: data from Nordic Society for Pediatric Hematology and Oncology …
ADL Espersen, U Noren‐Nyström… - Genes …, 2018 - Wiley Online Library
Abstract The t (7; 12)(q36; p13)(MNX1/ETV6) is not included in the WHO classification but
has been described in up to 30% of acute myeloid leukemia (AML) in children< 2 years and …
has been described in up to 30% of acute myeloid leukemia (AML) in children< 2 years and …
The Translocation t (7; 12)(q36; p13) in Childhood Acute Myeloid Leukemia
A Östlund - 2024 - gupea.ub.gu.se
The reciprocal translocation t (7; 12)(q36; p13) gives rise to acute myeloid leukemia (AML) in
infants and very young children. A fusion transcript MNX1:: ETV6 is sometimes detected and …
infants and very young children. A fusion transcript MNX1:: ETV6 is sometimes detected and …
Heterogeneous Gene Fusion Transcripts Found in t (7; 12)(q36; p13) Acute Myeloid Leukemia but with Similar Gene Expression Profile
A Östlund, A Staffas, U Norén-Nyström, H Hasle… - Blood, 2023 - Elsevier
Cytogenetic aberrations are often involved in acute myeloid leukemia (AML) and can serve
as diagnostic markers, prognosis predictors and impact the choice of therapy. A …
as diagnostic markers, prognosis predictors and impact the choice of therapy. A …
[HTML][HTML] Pediatric Acute Myeloid Leukemia with t (8; 16)(p11; p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin …
EA Coenen, CM Zwaan, CJ Harrison, OA Haas… - Blood, 2012 - Elsevier
Abstract Abstract 2516 Introduction: In pediatric acute myeloid leukemia (AML) cytogenetic
abnormalities are important for prognosis and treatment stratification. Some recurring …
abnormalities are important for prognosis and treatment stratification. Some recurring …
[HTML][HTML] A Pediatric Case of Acute Myeloid Leukemia with t (3; 5)(q25; q34)
BY Kim, I Jeon - Clinical Pediatric Hematology-Oncology, 2014 - cpho.or.kr
Acute myeloid leukemia (AML) with t (3; 5)(q25; q34), belonging to AML with myelodys-
plasia related changes according to WHO classification in 2008, is a subtype of AML that is …
plasia related changes according to WHO classification in 2008, is a subtype of AML that is …
Acute myeloid leukemia in an infant with t (8; 19)(p11. 2; q13) translocation: case report and a review of the literature
AC Eason, ST Bunting, JF Peterson… - Case reports in …, 2019 - Wiley Online Library
Acute myeloid leukemia (AML) patients with t (8; 16)(p11. 2; p13) constitute a small
subgroup with a distinct genetic and clinical profile. We present a unique case of a female …
subgroup with a distinct genetic and clinical profile. We present a unique case of a female …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster …
EA Coenen, CM Zwaan, D Reinhardt… - Blood, The Journal …, 2013 - ashpublications.org
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
[HTML][HTML] Translocation t (6; 9)(p22; q34)/DEK-NUP214 rearranged Pediatric AML: A Retrospective International Study
JD Sandahl, EA Coenen, E Forestier, J Harbott… - Blood, 2012 - Elsevier
Abstract 538 The cytogenetic subgroup t (6; 9)(p22; q34), previously often reported as a
breakpoint in 6p23, is defined as a distinct entity in the 2008 WHO classification of acute …
breakpoint in 6p23, is defined as a distinct entity in the 2008 WHO classification of acute …
[PDF][PDF] Pediatric Acute Myeloid Leukemia with t (8; 16)(p11; p13): a distinct clinical and biological entity.
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - 2013 - Citeseer
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …